Literature DB >> 21247248

The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors.

David W Emery1.   

Abstract

The therapeutic application of recombinant retroviruses and other integrating gene transfer vectors has been limited by problems of vector expression and vector-mediated genotoxicity. These problems arise in large part from the interactions between vector sequences and the genomic environment surrounding sites of integration. Strides have been made in overcoming both of these problems through the modification of deleterious vector sequences, the inclusion of better enhancers and promoters, and the use of alternative virus systems. However, these modifications often add other restrictions on vector design, which in turn can further limit therapeutic applications. As an alternative, several groups have been investigating a class of DNA regulatory elements known as chromatin insulators. These elements provide a means of blocking the interaction between an integrating vector and the target cell genome in a manner that is independent of the vector transgene, regulatory elements, or virus of origin. This review outlines the background, rationale, and evidence for using chromatin insulators to improve the expression and safety of gene transfer vectors. Also reviewed are topological factors that constrain the use of insulators in integrating gene transfer vectors, alternative sources of insulators, and the role of chromatin insulators as one of several components for optimal vector design.

Mesh:

Substances:

Year:  2011        PMID: 21247248      PMCID: PMC3107579          DOI: 10.1089/hum.2010.233

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  104 in total

1.  The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites.

Authors:  S Rivella; J A Callegari; C May; C W Tan; M Sadelain
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.

Authors:  D S Steinwaerder; A Lieber
Journal:  Gene Ther       Date:  2000-04       Impact factor: 5.250

3.  A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

Authors:  Sheng Zhou; Disha Mody; Suk See DeRavin; Julia Hauer; Taihe Lu; Zhijun Ma; Salima Hacein-Bey Abina; John T Gray; Michael R Greene; Marina Cavazzana-Calvo; Harry L Malech; Brian P Sorrentino
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

4.  Large double copy vectors are functional but show a size-dependent decline in transduction efficiency.

Authors:  Tomas J Bos; Elke De Bruyne; Sandra Van Lint; Carlo Heirman; Karin Vanderkerken
Journal:  J Biotechnol       Date:  2010-07-16       Impact factor: 3.307

5.  Poly(ADP-ribose) polymerase-1 (PARP-1) contributes to the barrier function of a vertebrate chromatin insulator.

Authors:  Mari Aker; Karol Bomsztyk; David W Emery
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

6.  Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis.

Authors:  Patrick G Gallagher; Laurie A Steiner; Robert I Liem; Ashley N Owen; Amanda P Cline; Nancy E Seidel; Lisa J Garrett; David M Bodine
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 7.  Insulators and promoters: closer than we think.

Authors:  Jesse R Raab; Rohinton T Kamakaka
Journal:  Nat Rev Genet       Date:  2010-05-05       Impact factor: 53.242

8.  Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.

Authors:  C May; S Rivella; J Callegari; G Heller; K M Gaensler; L Luzzatto; M Sadelain
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

9.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

10.  A functional screen for regulatory elements that improve retroviral vector gene expression.

Authors:  Amy C Groth; David W Emery
Journal:  Blood Cells Mol Dis       Date:  2010-09-16       Impact factor: 3.039

View more
  45 in total

Review 1.  Safe harbours for the integration of new DNA in the human genome.

Authors:  Michel Sadelain; Eirini P Papapetrou; Frederic D Bushman
Journal:  Nat Rev Cancer       Date:  2011-12-01       Impact factor: 60.716

Review 2.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

3.  Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver.

Authors:  Ali Nowrouzi; Magalie Penaud-Budloo; Christine Kaeppel; Uwe Appelt; Caroline Le Guiner; Philippe Moullier; Christof von Kalle; Richard O Snyder; Manfred Schmidt
Journal:  Mol Ther       Date:  2012-03-27       Impact factor: 11.454

4.  Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.

Authors:  Fang Han; Yoshitaka Miyagawa; Gianluca Verlengia; Selene Ingusci; Marie Soukupova; Michele Simonato; Joseph C Glorioso; Justus B Cohen
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

5.  ISWI contributes to ArsI insulator function in development of the sea urchin.

Authors:  Mamiko Yajima; William G Fairbrother; Gary M Wessel
Journal:  Development       Date:  2012-10       Impact factor: 6.868

Review 6.  Development of gene therapy for thalassemia.

Authors:  Arthur W Nienhuis; Derek A Persons
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

7.  Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells.

Authors:  D Hoffmann; J W Schott; F K Geis; L Lange; F-J Müller; D Lenz; D Zychlinski; D Steinemann; M Morgan; T Moritz; A Schambach
Journal:  Gene Ther       Date:  2017-04-20       Impact factor: 5.250

8.  Genomic discovery of potent chromatin insulators for human gene therapy.

Authors:  Mingdong Liu; Matthew T Maurano; Hao Wang; Heyuan Qi; Chao-Zhong Song; Patrick A Navas; David W Emery; John A Stamatoyannopoulos; George Stamatoyannopoulos
Journal:  Nat Biotechnol       Date:  2015-01-12       Impact factor: 54.908

Review 9.  Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.

Authors:  Alisa C Dong; Stefano Rivella
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

10.  Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.

Authors:  Michael R Greene; Timothy Lockey; Perdeep K Mehta; Yoon-Sang Kim; Paul W Eldridge; John T Gray; Brian P Sorrentino
Journal:  Hum Gene Ther Methods       Date:  2012-11-07       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.